Compare SPT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPT | TMDX |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 633.9M | 3.9B |
| IPO Year | 2019 | 2019 |
| Metric | SPT | TMDX |
|---|---|---|
| Price | $11.10 | $124.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 8 |
| Target Price | $26.00 | ★ $144.25 |
| AVG Volume (30 Days) | ★ 1.0M | 724.8K |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 170.70 |
| EPS | N/A | ★ 2.54 |
| Revenue | $443,750,000.00 | ★ $566,354,000.00 |
| Revenue This Year | $13.30 | $38.81 |
| Revenue Next Year | $11.37 | $20.49 |
| P/E Ratio | ★ N/A | $48.97 |
| Revenue Growth | 13.09 | ★ 41.20 |
| 52 Week Low | $9.16 | $55.00 |
| 52 Week High | $35.18 | $156.00 |
| Indicator | SPT | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 54.23 | 43.84 |
| Support Level | $10.98 | $120.82 |
| Resistance Level | $12.06 | $133.29 |
| Average True Range (ATR) | 0.45 | 5.52 |
| MACD | 0.04 | -0.91 |
| Stochastic Oscillator | 40.84 | 19.55 |
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.